High Court Asked To Review 2nd Circ. Fosamax Ruling
A one-time user of the bone drug Fosamax urged the U.S. Supreme Court on Wednesday to review the Second Circuit's ruling in favor of Merck & Co. in multidistrict litigation over...To view the full article, register now.
Already a subscriber? Click here to view full article